Fox Chase Cancer Center

 

Genitourinary Malignancies in the Time of COVID-19
10:43

Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Update on mUC: 1L, Maintenance, and 2L Treatment Options

FEATURING Pooja Ghatalia
  • 106 views
  • March 1, 2021
  • 1
13:36

Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Updates on mRCC: Surveying Options for 1L, 2L and Beyond

FEATURING Matthew Zibelman
  • 188 views
  • March 1, 2021
  • 1
08:23

Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

New Data on Adjuvant vs. Salvage RT for PC: Is Early Salvage the Preferred Treatment? Who Should Be Directed to Adjuvant RT? When to Consider ADT?

FEATURING Jessica Wong
  • 215 views
  • March 1, 2021
  • 2
12:55

Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

mPC Fox Chase Update: Is There OS Benefit With Abi/Pred + ADT vs. ADT Alone? What Is the Role of Oral ADT? How Effective Are Rucaparib & Olaparib in BRCA1/2 or HRR-Mutated mCRPC?

FEATURING Fern Anari
  • 63 views
  • March 1, 2021
11:47

Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Experience on COVID-19 & Cancer: Disease Biology, Risks of Systemic Treatment Delivery During the Pandemic, SARS-CoV-2 Testing & Vaccines

FEATURING Alexander Kutikov
  • 8 views
  • March 1, 2021
16:47

Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase COVID-19 Updates on Surgery for Bladder, Kidney & Prostate Cancer: Can We Delay Treatment? Is It Safe?

FEATURING Rosalia Viterbo
  • 3 views
  • March 1, 2021